1. Home
  2. KPLT vs EMBC Comparison

KPLT vs EMBC Comparison

Compare KPLT & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Katapult Holdings Inc.

KPLT

Katapult Holdings Inc.

N/A

Current Price

$11.25

Market Cap

392.0M

ML Signal

N/A

Logo Embecta Corp.

EMBC

Embecta Corp.

N/A

Current Price

$6.41

Market Cap

354.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KPLT
EMBC
Founded
2012
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
392.0M
354.1M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
KPLT
EMBC
Price
$11.25
$6.41
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
★ $4.00
AVG Volume (30 Days)
360.8K
★ 781.8K
Earning Date
11-12-2026
11-24-2026
Dividend Yield
N/A
★ 0.62%
EPS Growth
★ 98.15
20.90
EPS
N/A
★ 1.03
Revenue
★ $291,761,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.69
$5.59
P/E Ratio
★ N/A
$6.19
Revenue Growth
★ 18.03
N/A
52 Week Low
$3.85
$2.77
52 Week High
$12.68
$14.91

Technical Indicators

Market Signals
Indicator
KPLT
EMBC
Relative Strength Index (RSI) 63.68 54.37
Support Level $6.09 $3.01
Resistance Level $12.68 $6.90
Average True Range (ATR) 1.35 0.32
MACD 0.21 -0.05
Stochastic Oscillator 73.48 55.80

Price Performance

Historical Comparison
KPLT
EMBC

About KPLT Katapult Holdings Inc.

Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: